Intravenous drips for mycoplasma pneumonia take several days

Generally, patients with mild mycoplasma pneumonia are preferred to be treated with oral drugs, and for those with severe symptoms or accompanied by other diseases, intravenous administration can be chosen, and intravenous infusion can generally be given for 3-7 days.

Mycoplasma pneumonia is a lung interstitial lesion caused by Mycoplasma pneumoniae infection, resulting in symptoms such as body aches, dry cough, and fever, and this type of bacterium is sensitive to macrolides, such as azithromycin, erythromycin, etc., as well as quinolones, such as levofloxacin.

Generally, oral medication is chosen, but for some severe patients, oral administration cannot be allowed, or those with other underlying diseases can choose intravenous administration, generally intravenous administration for 3-7 days, and the drug can be stopped in time according to the patient's symptoms, and oral administration can be changed in the later stage. Generally, the total course of treatment is about 7~14 days. Some patients with severe disease may take the drug for a longer period of time.

It should be noted that the adverse reactions of the drug may include gastrointestinal such as nausea and vomiting, systemic such as allergic reactions, liver and kidney damage, etc., and the liver and kidney function should be monitored during the medication.

The above is for reference only, patients with mycoplasma pneumonia need to see a doctor in time, and under the guidance of a physician, a personalized treatment plan should be formulated according to the patient's condition. The above drugs should be standardized and rationally used under the guidance of professional physicians and pharmacists.